Amendment No. 4 to Schedule 13D
The following constitutes Amendment No. 4 (“Amendment No. 4”) to the Schedule 13D filed with the Securities and Exchange Commission (the “SEC”) by First Pacific Advisors, LLC, FPA Crescent Fund, a series of FPA Funds Trust, FPA Global Opportunity Fund, a series of FPA Hawkeye Fund, LLC, FPA Select Drawdown Fund, L.P., FPA Select Fund, a series of FPA Hawkeye Fund, LLC, FPA Value Partners Fund, a series of FPA Hawkeye Fund, LLC, J. Richard Atwood, Steven T. Romick, Brian A. Selmo, and Mark Landecker on June 20, 2016, as amended by Amendment No. 1 filed on August 24, 2017, Amendment No. 2 filed on September 20, 2017, and Amendment No. 3 filed on September 19, 2018. This Amendment No. 4 amends and supplements the Schedule 13D as specifically set forth herein.
All capitalized terms contained herein but not otherwise defined shall have the meanings ascribed to such terms in the Schedule 13D, as amended. Information given in response to each item shall be deemed incorporated by reference in all other items, as applicable.
ITEM 4. PURPOSE OF TRANSACTION
Item 4 of Schedule 13D is supplemented and superseded, as the case may be, as follows:
On February 28, 2019, Univar Inc. (“Univar”) completed its previously announced acquisition of Nexeo Solutions, Inc. (the “Issuer”), pursuant to the Agreement and Plan of Merger, dated September 17, 2018 (the “Merger Agreement”), among the Issuer, Univar, Pilates Merger Sub I Corp. (“Merger Sub I”), and Pilates Merger Sub II LLC (“Merger Sub II”). Pursuant to the terms of the Merger Agreement (i) Merger Sub I merged with and into the Issuer (the “Initial Merger”), with the Issuer surviving the Initial Merger as a wholly owned subsidiary of Univar, and (ii) immediately following the Initial Merger, the Issuer merged with and into Merger Sub II, with Merger Sub II surviving as the surviving company and wholly owned subsidiary of Univar in the Subsequent Merger.
In connection with the Initial Merger, each full share of Common Stock issued and outstanding immediately prior to the effective time of the Initial Merger (such time, the “Initial Effective Time”) (other than (i) Common Stock owned by Univar, the Issuer or any direct or indirect wholly owned subsidiary of the Issuer or Univar (including Merger Sub I and Merger Sub II) and (ii) Common Stock owned by stockholders who have perfected and not withdrawn a demand for appraisal rights pursuant to the Delaware General Corporations Law, as amended) was converted into the right to receive (A) $3.02, and (B) 0.305 of a share of common stock of Univar (collectively, the “Merger Consideration”). The Reporting Persons disposed of all shares of Common Stock beneficially owned by them in connection with the Initial Merger and received the right to receive the Merger Consideration. The shares of Common Stock that were disposed of by FPA Crescent Fund and the Managed Accounts in connection with the Initial Merger included shares of Common Stock received by FPA Crescent Fund and the Managed Accounts in a pro rata distribution for no consideration by WLRS Fund I LLC.
Following the Initial Effective Time, each outstanding and unexercised warrant to purchase Common Stock (“Issuer Warrant”) became exercisable for 0.1525 shares of common stock of Univar and $1.51 in cash, which represents the Merger Consideration that would have been payable in respect of theone-half (1/2) share of Common Stock that the holder of each Issuer Warrant would have been entitled to receive had such holder exercised such Issuer Warrant immediately prior to the Initial Effective Time, upon the terms and conditions specified in Issuer Warrants and the Warrant Agreement governing such Issuer Warrants. The Issuer Warrants held by FPA Value Partners were converted as described in the previous sentence following the Initial Effective Time.
ITEM 5. INTEREST IN SECURITIES OF THE ISSUER
Item 5 of this Schedule 13D is hereby amended and restated in its entirety as follows:
(a) and (b) Items 7 through 11 and 13 of each of the cover pages of this Schedule 13D are incorporated herein by reference.
(c) The disclosure in Item 4 is incorporated herein by reference. Except as disclosed in Item 4 herein, there have been no transactions in securities of the Issuer during the 60 days prior to the date hereof by any of the Reporting Persons.